Andrew Silvera
Psychiatry · New Orleans, LANPI 1356927982
Payments from drug & device makers
Across 115 payments — averaging $22.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$663
- Otsuka America Pharmaceutical, Inc.$562
- AbbVie$305
- Johnson & Johnson$232
- Teva Pharmaceuticals USA, Inc.$186
- Idorsia Pharmaceuticals US Inc$134
- plus $505 from 10 others
What the payments were for
- Food & beverage$2,54999%
- Education$391%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 35 | $663 |
| Otsuka America Pharmaceutical, Inc. | 29 | $562 |
| AbbVie | 7 | $305 |
| Johnson & Johnson | 7 | $232 |
| Teva Pharmaceuticals USA, Inc. | 14 | $186 |
| Idorsia Pharmaceuticals US Inc | 1 | $134 |
| Neurocrine Biosciences, Inc. | 3 | $122 |
| Indivior Inc. | 3 | $66 |
| Tris Pharma Inc | 4 | $61 |
| Axsome Therapeutics, Inc. | 3 | $58 |
| Lundbeck LLC | 2 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $38 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $32 |
| Luye Pharma (USA) Ltd. | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$242
- QUVIVIQ$134
- ABILIFY MAINTENA$108
- ABILIFY ASIMTUFII$108
How this compares
$2,587 in reported general payments places this provider in the 75th percentile of 474 psychiatry providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mirtazapine | 15 | $209 |
| Bupropion XlBupropion Hcl | 11 | $150 |
| Escitalopram Oxalate | 17 | $49 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in New Orleans
- Arwen PodestaNew Orleans$466K
- Andrew MorsonNew Orleans$56K
- James BarbeeNew Orleans$28K
- Neha KansaraNew Orleans$13K
- Erich ConradNew Orleans$9K
- Rahn BaileyNew Orleans$8K
- Nick RamandiNew Orleans$8K
- Ashley WeissNew Orleans$8K
- Ravindra ReddyNew Orleans$7K
- Paul PeltsNew Orleans$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.